Hungarian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
venous thrombosis/protease
A hivatkozás a vágólapra kerül
Oldal 1 tól től 195 eredmények
A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
The protein Z-dependent protease inhibitor (ZPI) is a hemostatic serpin with anticoagulant activity. As for antithrombin, deficiency of ZPI could have relevant thrombotic consequences. We have studied 6 genetic modifications affecting the ZPI gene, identifying 5 haplotypes. Haplotype H5 is featured
Two missense mutations identified in venous thrombosis patients impair the inhibitory function of the protein Z dependent protease inhibitor.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
Protein Z-dependent protease inhibitor (ZPI) is a plasma inhibitor of factor (F)Xa and FXIa. In an earlier study, five mutations were identified within the ZPI gene of venous thrombosis patients and healthy controls. Two of these were nonsense mutations and three were missense mutations in important
Factor VII-activating protease in patients with acute deep venous thrombosis.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
Factor VII-activating protease (FSAP) is involved in haemostasis and inflammation. FSAP cleaves single chain urokinase-type plasminogen activator (scu-PA). The 1601GA genotype of the 1601G/A polymorphism in the FSAP gene leads to the expression of a FSAP variant with reduced ability to activate
The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
BACKGROUND
A single nucleotide polymorphism of the factor VII activating protease (FSAP), FSAP Marburg I (rs7080536) has been identified as a risk factor for venous thrombosis, but its clinical role has so far been controversial in part due to small cohort sizes. The aim of the present case-control
Single Nucleotide Variant rs2232710 in the Protein Z-Dependent Protease Inhibitor (ZPI, SERPINA10) Gene Is Not Associated with Deep Vein Thrombosis.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
Rare mutations in PROC, PROS1 or SERPINC1 as well as common variants in F5, F2, F11 and SERPINC1 have been identified as risk factors for deep vein thrombosis (DVT). To identify novel genetic risk factors for DVT, we have developed and applied next-generation DNA sequencing (NGS) of the coding area
Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
To assess the potential roles of protein Z (PZ) and protein Z-dependent protease inhibitor (ZPI) in venous thrombosis, their plasma levels were measured in 426 individuals with venous thrombosis and 471 control individuals participating in the Leiden Thrombophilia Study. A relationship between the
An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
Sulfated galactan from the red alga Botryocladia occidentalis has a potent anticoagulant activity, due to its ability to enhance thrombin and factor Xa inhibition by antithrombin and/or heparin cofactor II. It is less active than unfractionated heparin in arterial thrombosis, but in a venous
Thrombolysis with a snake venom protease in a rat model of venous thrombosis.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
A fibrin(ogen)olytic protease isolated from the venom of Crotalus atrox (the western diamondback rattlesnake) was tested for thrombolytic activity. The protease, called atroxase, solubilized fibrin when tested on fibrin plates and hydrolyzed fibrinogen rendering it incoagulable with a specific
Autoantibodies against the protease inhibitor calpastatin: a new risk factor for venous thrombosis?
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
Autoantibodies reactive against human calpastatin were detected by screening a cDNA expression library with the serum of a 53 year old white female patient with a history of venous thrombosis and suspected antiphospholipid syndrome. When further sera were analyzed it could be shown that > 90% of
Protein Z-dependent protease inhibitor W303X mutation in venous thrombosis.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
Protease activated receptor 1 gene -506 I / D polymorphism in cancer patients with and without venous thrombosis.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
Fibrin(ogen)olytic and antiplatelet activities of a subtilisin-like protease from Solanum tuberosum (StSBTc-3).
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
Plant serine proteases have been widely used in food science and technology as well as in medicine. In this sense, several plant serine proteases have been proposed as potential anti-coagulants and anti-platelet agents. Previously, we have reported the purification and identification of a plant
Effect of activated human protein C on experimental venous thrombosis induced by stasis with operative invasion in mice.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
Protein C (PC) is the zymogen of an anticoagulant serine protease and is converted to its active form (activated protein C: APC) by thrombin in the presence of thrombomodulin. APC plays an important role in regulating blood coagulation and fibrinolysis by inhibiting not only blood coagulation
The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis.
Csak regisztrált felhasználók fordíthatnak cikkeket
Belépés Regisztrálás
Factor Xa is a serine protease positioned at the convergence point of the intrinsic and extrinsic coagulation pathways and is therefore an attractive target in the development of novel anticoagulant drugs. The objective of this study was to evaluate the efficacy of CI-1031
A legteljesebb gyógynövény-adatbázis, amelyet a tudomány támogat
- Működik 55 nyelven
- A tudomány által támogatott gyógynövényes kúrák
- Gyógynövények felismerése kép alapján
- Interaktív GPS térkép - jelölje meg a gyógynövényeket a helyszínen (hamarosan)
- Olvassa el a keresésével kapcsolatos tudományos publikációkat
- Keresse meg a gyógynövényeket hatásuk szerint
- Szervezze meg érdeklődését, és naprakész legyen a hírkutatással, a klinikai vizsgálatokkal és a szabadalmakkal
Írjon be egy tünetet vagy betegséget, és olvassa el azokat a gyógynövényeket, amelyek segíthetnek, beírhat egy gyógynövényt, és megtekintheti azokat a betegségeket és tüneteket, amelyek ellen használják.
* Minden információ publikált tudományos kutatáson alapul
